5-(Methanesulfonyl)-2,3-dihydro-1H-indole → tert-Butyl-4-((4-(5-(methylsulfonyl)indolin-1-yl)thiazol-2-yl)oxy)-piperidine-1-carboxylate

HRID 1468067Notes

Reaction equation

HRID 1468067 reaction equation
[CH3:1][S:2]([C:5]1[CH:6]=[C:7]2[C:11](=[CH:12][CH:13]=1)[NH:10][CH2:9][CH2:8]2)(=[O:4])=[O:3].Br[C:15]1[N:16]=[C:17]([O:20][CH:21]2[CH2:26][CH2:25][N:24]([C:27]([O:29][C:30]([CH3:33])([CH3:32])[CH3:31])=[O:28])[CH2:23][CH2:22]2)[S:18][CH:19]=1>>[C:30]([O:29][C:27]([N:24]1[CH2:23][CH2:22][CH:21]([O:20][C:17]2[S:18][CH:19]=[C:15]([N:10]3[C:11]4[C:7](=[CH:6][C:5]([S:2]([CH3:1])(=[O:4])=[O:3])=[CH:13][CH:12]=4)[CH2:8][CH2:9]3)[N:16]=2)[CH2:26][CH2:25]1)=[O:28])([CH3:33])([CH3:31])[CH3:32]

Participants

3

Procedure

The title compound was prepared by following the similar procedure as described in Example-1 using 5-(methylsulfonyl)indoline (intermediate 26) and tert-Butyl 4-((4-bromothiazol-2-yl)oxy)piperidine-1-carboxylate (intermediate 46).

Sources & evidence

ORD record
ord-10e01075cdf94794ab8593bc2304a349
Source dataset
uspto-grants-2015_04
Patent number
US09000175B2

Reaction notes

Loading…